BioLife Solutions (BLFS) Tops Q2 EPS by 2c

BioLife Solutions (NASDAQ: BLFS) reported Q2 EPS of ($0.19), $0.02 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $40.5 million versus the consensus estimate of $39.17 million.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c